NASDAQ:NKTR Investor Notice: Lawsuit Alleges Securities Laws Violations by Nektar Therapeutics
An investor, who purchased shares of Nektar Therapeutics (NASDAQ: NKTR), filed a lawsuit over alleged violations of Federal Securities Laws by Nektar Therapeutics.
View full press release